Navigation Links
Henry Ford Hospital: New left-side heart pump improves right-side heart function
Date:5/27/2010

A state-of-the-art heart pump, designed to maintain a continuous flow of blood in end-stage cardiac patients with damage to the left side of the heart, also improves function on the right side of the heart, according to researchers at Henry Ford Hospital's Heart and Vascular Institute.

"Very little has been published regarding the ability of continuous flow pumps to have similar effects on the right ventricle," says study lead author Jeffrey Morgan, M.D., director of Cardiac Surgery Research at Henry Ford Hospital. "So we set out to evaluate its short-term and mid-term effects on central venous pressure and pulmonary artery pressures, on the severity of tricuspid regurgitation, as well as on the functioning of the right ventricle."

The study will be presented May 27 at the American Society for Artificial Internal Organs in Baltimore.

The pump, a left ventricular assist device (LVAD) known as the HeartMate II, was developed by Thoratec Corporation. LVADs are used to treat patients who are not candidates for heart transplant, and offer the advantage of being replaceable.

When implanted just below the heart and connected to a patient's diseased left ventricle the heart chamber that pumps blood into the body through the aorta it provides a constant, rather than a pulsing, flow. The only moving part in the HeartMate II is a tiny turbine with synthetic ruby bearings, lubricated by the blood itself. It's powered by a battery pack worn outside the body and connected by wires through the chest wall.

An earlier version of the device, which was larger and more complicated, was designed to mimic the heart's natural pulsing, but its size and the intricacies of its mechanism called for a simpler, smaller device that could also be used in more and physically smaller heart patients. Those implanted with the newer device have virtually no pulse because of the continuous blood flow.

Earlier studies showed that the pulsing, left-side version improved pressure in the pulmonary artery, which carries blood to the lungs from the right ventricle; improved function in the right ventricle; and reduced the severity of tricuspid regurgitation, a disorder that causes blood to leak back into the heart's atrium the upper chamber on the right side through the valve that's supposed to prevent such backward flow.

For the Henry Ford study, researchers monitored 41 patients, who were implanted with the HeartMate II to treat chronic heart failure, from March 2006 to July 2009. The mean age of the study group was just over 52 years.

At the end of the study, they found significant improvements in all of six measures included in the research, similar to published data for the earlier version of the HeartMate.

A companion study from Henry Ford also found that the HeartMate II, which is implanted in a much less invasive surgical procedure than its predecessor, also carried a far smaller risk of infections related to the device.


'/>"/>

Contact: Dwight Angell
dwight.angell@hfhs.org
313-876-8709
Henry Ford Health System
Source:Eurekalert

Related medicine news :

1. iCIMS Emerges as Talent Management Solution of Choice for Henry Ford Health Systems
2. Health Care Pioneer Henry J. Kaiser Inducted Into The California Hall of Fame
3. National Press Club to Host NEWSMAKER Media Briefing on Cornhusker Kickback With South Carolina Attorney General Henry McMaster
4. Alan Henry, M.D. Joins MedSolutions as Chief Medical Officer of Premerus
5. Henry Ford Hospital study shows link between vitamin D, skin cancer
6. Henry Ford Hospital study: Shoulder function not fully restored after surgery
7. Henry Ford Hospital atudy: Hepatitis C infection doubles risk for kidney cancer
8. Henry Ford Health System goes radical: Creating the hospital of the future
9. Henry Ford Hospital study: Less prep needed for colonoscopy
10. Fewer left-sided colorectal tumors observed after colonoscopies
11. New research identifies modifiable risk factors for heart disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... ... ‘17, and Jennifer Huggins, PharmD ’17, along with clinical associate professor Janice ... of cardiovascular diseases during the 15th Annual Women’s Health Conference. The SIU ...
(Date:10/13/2017)... ... ... The Visiting Nurse Association (VNA) of Somerset Hills is proud to host ... items from across the nation, this holiday-themed event will raise funds and awareness for ... The boutique will be open Saturday, November 4 (10:00 a.m. – 5:00 p.m.) ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, actor Rob ... sciatica in a new episode of "Success Files," which is an award-winning educational ... and investigates each subject in-depth with passion and integrity. , Sciatica occurs when ...
(Date:10/12/2017)... ... 2017 , ... First Healthcare Compliance (FHC), an industry leader ... range of technology and learning solutions at the 68th Annual American Healthcare Association ... held October 14–18, 2017 at the Mandalay Bay Resort in Las Vegas, Nevada. ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( ... today the introduction of an innovative new design of the shoulder pad. The ... get maximum comfort while controlling your pain while using cold therapy. By utilizing ice ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... 2, 2017 The Rebound mobile app is poised ... reverse the tide of prescription drug addiction. The app empowers ... intake and stepping down their dosage in a safe, controlled ... December 2017; the first 100,000 people to sign up will ... http://www.rebound-solution.com/ ...
(Date:9/27/2017)... 2017  Commended for their devotion to personalized service, SMP ... number one in the South Florida Business Journal,s 50 Fastest-Growing ... yearly list, the national specialty pharmacy has found its niche.  ... will soon be honored by SFBJ as the 2017 Power ... Set to receive his award in October, Bardisa said of ...
(Date:9/25/2017)... Sept. 25, 2017  EpiVax, Inc., a leader ... and immune-engineering today announced the launch of EpiVax ... of personalized therapeutic cancer vaccines. EpiVax has provided ... access to enabling technologies to the new precision ... lead EpiVax Oncology as Chief Executive Officer. Gad ...
Breaking Medicine Technology: